Answers., Exams of Nursing
Climacteric phase - ANSWERThe period of endrocrinologic, somatic, and
transitory psychologic changes that occur around the time of menopause.
Early menopause - ANSWERLMP before age 45
Late menopause - ANSWERLMP after age 54
Primary ovarian insufficiency - ANSWERMenopause that occurs before age 40
Early menopause transition (stage -2) - ANSWERPersistent difference of 7
days or more in the length of consecutive cycles.
Late menopause transition (stage -1) - ANSWER60 or more consecutive days
of amenorrhea
Luteal out of phase event (LOOP) - ANSWERExplains why some
perimenopausal women have elevated estrogen level sometimes...In the early
menopause transition, elevated FSH levels are adequate to recruit a second
follicle which results in a follicular phase-like rise in estradiol secretion
superimposed on the mid-to-late luteal phase of the ongoing ovulatory cycle.
,Obese women and estradiol levels during menopause - ANSWERObese
women are more likely to have anovulatory cycles with high estradiol levels.
They are also more likely to have lower premenopause yet higher
postmenopause estradiol levels compared with women of normal weight.
(why they are at higher risk of endometrial cancer)
Chinese and Japanese women - ANSWERThese ethnic groups have lower
estradiol levels then white, black and hispanic women.
stage +2 - ANSWERlate menopause stage: 5-8 years after FMP. Somatic aging
predominates. Increased genitourinary symptoms.
Stages +1a, +1b, +1c - ANSWERearly post menopause: 2 years after FMP. FSH
rises, estradiol decreases. VMS predominate.
Elevated FSH, LH - ANSWEREndocrine labs after menopause
AMH, inhibin B - ANSWERThese hormones work during reproductive years to
not deplete follicle pool too quickly.
Phases during menopause transition and PMS symptoms -
ANSWERMenstrual cycle shortenes, follicular phase compresses, women
spend more time in luteal phase.. meaning more premenstrual symptoms
and more frequent menstrual periods.
How to respond if a patient requests FSH lab? - ANSWERmany pitfalls,
variable depending on the day of the cycle you draw the lab, normal or low
FSH is not helpful.
, The potentially superior marker of menopause, a lab. - ANSWERAMH
DHEA (dehydroepiandrosterone) - ANSWERAdrenal androgens: precursor
hromones produced by the adrenal gland that are enzymatically converted to
active androgens or estrogens in peripheral tissues.
Location of estrogen receptors - ANSWERVagina, vulva, urethra, trigone of
the bladder
Effects of estrogen on tissue - ANSWERmaintain blood flow, the collagen, and
HA within the epithelial surfaces. Supports microbiome and protects tissue
from pathogens.
Vaginal changes with menopause - ANSWERThinning, loss of elasticity, loss or
absence or rugae.
Vagina and urethra in menopause - ANSWERvagina narrows, urethra moves
closer to the introitus.
Stress urinary incontinence - ANSWERVaginal estrogen and urinary
incontinence: what type does it help with?
Treatment for FPHL - ANSWERMinoxidil, spironolactone, finasteride, estrogen
therapy
Late reporoductive years -3b and -3a. What happens with menstrual cycles,
FSH, AMH, AFC, inhibin? - ANSWER-3b: menstrual cycles normal, FSH normal,
AMH low, AFC low, inhibin low.